Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of...
Gespeichert in:
Veröffentlicht in: | Modern pathology 2015-08, Vol.28 (8), p.1101-1122 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1122 |
---|---|
container_issue | 8 |
container_start_page | 1101 |
container_title | Modern pathology |
container_volume | 28 |
creator | McCluggage, W Glenn Judge, Meagan J Clarke, Blaise A Davidson, Ben Gilks, C Blake Hollema, Harry Ledermann, Jonathan A Matias-Guiu, Xavier Mikami, Yoshiki Stewart, Colin JR Vang, Russell Hirschowitz, Lynn |
description | A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the ‘required’ and ‘recommended’ elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management. |
doi_str_mv | 10.1038/modpathol.2015.77 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1720454624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1720454624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c551t-f48a6be27c96cbaad97646612ee9d79b0f411e99c35c00f5a3efb5877a81c1d73</originalsourceid><addsrcrecordid>eNp1kV2L1DAUhoMo7uzqD_BGAt7sgh3z0TSNd1K_BhaERa_LaXq626VNapIK_hz_qZmdcRBBCITkPOc9b_IS8oKzLWeyfjP7foF056etYFxttX5ENlxJVjBRq8dkw2ojC2mUOCPnMd4zxktVi6fkTFS5xIzYkF_vIQGNmOjgAw24-JBGd0v9QP0PCD9f0wGmyS8jOJrWDim4ni5hnHONLhjG5B3CRC0EOzo_w9ssYv08o-shjd5FOgQ_03SHdOcSBvdwmzsaP03Q-fBwpnk14CwGenPycLlrmpurZ-RJthDx-XG_IN8-fvjafC6uv3zaNe-uC6sUT8VQ1lB1KLQ1le0AeqOrsqq4QDS9Nh0bSs7RGCuVZWxQIHHoVK011NzyXssLcnnQXYL_vmJM7TxGi9mkQ7_GlmvBSlVWoszoq3_Qe7_ml017ijEpWWVkpviBssHHGHBoj__Wctbu82tP-bX7_Fq9N_HyqLx2M_anjj-BZUAcgJhL7hbDX6P_q_obCD-sxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1700330693</pqid></control><display><type>article</type><title>Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>McCluggage, W Glenn ; Judge, Meagan J ; Clarke, Blaise A ; Davidson, Ben ; Gilks, C Blake ; Hollema, Harry ; Ledermann, Jonathan A ; Matias-Guiu, Xavier ; Mikami, Yoshiki ; Stewart, Colin JR ; Vang, Russell ; Hirschowitz, Lynn</creator><creatorcontrib>McCluggage, W Glenn ; Judge, Meagan J ; Clarke, Blaise A ; Davidson, Ben ; Gilks, C Blake ; Hollema, Harry ; Ledermann, Jonathan A ; Matias-Guiu, Xavier ; Mikami, Yoshiki ; Stewart, Colin JR ; Vang, Russell ; Hirschowitz, Lynn ; International Collaboration on Cancer Reporting</creatorcontrib><description>A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the ‘required’ and ‘recommended’ elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.</description><identifier>ISSN: 0893-3952</identifier><identifier>EISSN: 1530-0285</identifier><identifier>DOI: 10.1038/modpathol.2015.77</identifier><identifier>PMID: 26089092</identifier><identifier>CODEN: MODPEO</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>13/51 ; 692/420 ; 692/420/755 ; 692/699 ; 692/699/67/1517/1709 ; Alliances ; Biomarkers, Tumor - analysis ; Biomarkers, Tumor - genetics ; Biopsy - standards ; Cancer ; Carcinoma - chemistry ; Carcinoma - drug therapy ; Carcinoma - genetics ; Carcinoma - pathology ; Carcinoma - surgery ; Chemotherapy, Adjuvant ; Collaboration ; Datasets ; Diagnosis, Differential ; Fallopian Tube Neoplasms - chemistry ; Fallopian Tube Neoplasms - drug therapy ; Fallopian Tube Neoplasms - genetics ; Fallopian Tube Neoplasms - pathology ; Fallopian Tube Neoplasms - surgery ; Fallopian tubes ; Female ; Gynecology ; Hospitals ; Humans ; Immunohistochemistry - standards ; Laboratory Medicine ; Libraries ; Medicine ; Medicine & Public Health ; Molecular Diagnostic Techniques - standards ; Neoadjuvant Therapy ; Neoplasm Grading ; Neoplasm Staging ; original-article ; Ovarian Neoplasms - chemistry ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Ovaries ; Pathology ; Pathology, Clinical - standards ; Peritoneal Neoplasms - chemistry ; Peritoneal Neoplasms - drug therapy ; Peritoneal Neoplasms - genetics ; Peritoneal Neoplasms - pathology ; Peritoneal Neoplasms - surgery ; Predictive Value of Tests ; Research Design - standards</subject><ispartof>Modern pathology, 2015-08, Vol.28 (8), p.1101-1122</ispartof><rights>United States & Canadian Academy of Pathology 2015</rights><rights>Copyright Nature Publishing Group Aug 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c551t-f48a6be27c96cbaad97646612ee9d79b0f411e99c35c00f5a3efb5877a81c1d73</citedby><cites>FETCH-LOGICAL-c551t-f48a6be27c96cbaad97646612ee9d79b0f411e99c35c00f5a3efb5877a81c1d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26089092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McCluggage, W Glenn</creatorcontrib><creatorcontrib>Judge, Meagan J</creatorcontrib><creatorcontrib>Clarke, Blaise A</creatorcontrib><creatorcontrib>Davidson, Ben</creatorcontrib><creatorcontrib>Gilks, C Blake</creatorcontrib><creatorcontrib>Hollema, Harry</creatorcontrib><creatorcontrib>Ledermann, Jonathan A</creatorcontrib><creatorcontrib>Matias-Guiu, Xavier</creatorcontrib><creatorcontrib>Mikami, Yoshiki</creatorcontrib><creatorcontrib>Stewart, Colin JR</creatorcontrib><creatorcontrib>Vang, Russell</creatorcontrib><creatorcontrib>Hirschowitz, Lynn</creatorcontrib><creatorcontrib>International Collaboration on Cancer Reporting</creatorcontrib><title>Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><title>Modern pathology</title><addtitle>Mod Pathol</addtitle><addtitle>Mod Pathol</addtitle><description>A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the ‘required’ and ‘recommended’ elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.</description><subject>13/51</subject><subject>692/420</subject><subject>692/420/755</subject><subject>692/699</subject><subject>692/699/67/1517/1709</subject><subject>Alliances</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biopsy - standards</subject><subject>Cancer</subject><subject>Carcinoma - chemistry</subject><subject>Carcinoma - drug therapy</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Chemotherapy, Adjuvant</subject><subject>Collaboration</subject><subject>Datasets</subject><subject>Diagnosis, Differential</subject><subject>Fallopian Tube Neoplasms - chemistry</subject><subject>Fallopian Tube Neoplasms - drug therapy</subject><subject>Fallopian Tube Neoplasms - genetics</subject><subject>Fallopian Tube Neoplasms - pathology</subject><subject>Fallopian Tube Neoplasms - surgery</subject><subject>Fallopian tubes</subject><subject>Female</subject><subject>Gynecology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immunohistochemistry - standards</subject><subject>Laboratory Medicine</subject><subject>Libraries</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Molecular Diagnostic Techniques - standards</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>original-article</subject><subject>Ovarian Neoplasms - chemistry</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Ovaries</subject><subject>Pathology</subject><subject>Pathology, Clinical - standards</subject><subject>Peritoneal Neoplasms - chemistry</subject><subject>Peritoneal Neoplasms - drug therapy</subject><subject>Peritoneal Neoplasms - genetics</subject><subject>Peritoneal Neoplasms - pathology</subject><subject>Peritoneal Neoplasms - surgery</subject><subject>Predictive Value of Tests</subject><subject>Research Design - standards</subject><issn>0893-3952</issn><issn>1530-0285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kV2L1DAUhoMo7uzqD_BGAt7sgh3z0TSNd1K_BhaERa_LaXq626VNapIK_hz_qZmdcRBBCITkPOc9b_IS8oKzLWeyfjP7foF056etYFxttX5ENlxJVjBRq8dkw2ojC2mUOCPnMd4zxktVi6fkTFS5xIzYkF_vIQGNmOjgAw24-JBGd0v9QP0PCD9f0wGmyS8jOJrWDim4ni5hnHONLhjG5B3CRC0EOzo_w9ssYv08o-shjd5FOgQ_03SHdOcSBvdwmzsaP03Q-fBwpnk14CwGenPycLlrmpurZ-RJthDx-XG_IN8-fvjafC6uv3zaNe-uC6sUT8VQ1lB1KLQ1le0AeqOrsqq4QDS9Nh0bSs7RGCuVZWxQIHHoVK011NzyXssLcnnQXYL_vmJM7TxGi9mkQ7_GlmvBSlVWoszoq3_Qe7_ml017ijEpWWVkpviBssHHGHBoj__Wctbu82tP-bX7_Fq9N_HyqLx2M_anjj-BZUAcgJhL7hbDX6P_q_obCD-sxA</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>McCluggage, W Glenn</creator><creator>Judge, Meagan J</creator><creator>Clarke, Blaise A</creator><creator>Davidson, Ben</creator><creator>Gilks, C Blake</creator><creator>Hollema, Harry</creator><creator>Ledermann, Jonathan A</creator><creator>Matias-Guiu, Xavier</creator><creator>Mikami, Yoshiki</creator><creator>Stewart, Colin JR</creator><creator>Vang, Russell</creator><creator>Hirschowitz, Lynn</creator><general>Nature Publishing Group US</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)</title><author>McCluggage, W Glenn ; Judge, Meagan J ; Clarke, Blaise A ; Davidson, Ben ; Gilks, C Blake ; Hollema, Harry ; Ledermann, Jonathan A ; Matias-Guiu, Xavier ; Mikami, Yoshiki ; Stewart, Colin JR ; Vang, Russell ; Hirschowitz, Lynn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c551t-f48a6be27c96cbaad97646612ee9d79b0f411e99c35c00f5a3efb5877a81c1d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>13/51</topic><topic>692/420</topic><topic>692/420/755</topic><topic>692/699</topic><topic>692/699/67/1517/1709</topic><topic>Alliances</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biopsy - standards</topic><topic>Cancer</topic><topic>Carcinoma - chemistry</topic><topic>Carcinoma - drug therapy</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Chemotherapy, Adjuvant</topic><topic>Collaboration</topic><topic>Datasets</topic><topic>Diagnosis, Differential</topic><topic>Fallopian Tube Neoplasms - chemistry</topic><topic>Fallopian Tube Neoplasms - drug therapy</topic><topic>Fallopian Tube Neoplasms - genetics</topic><topic>Fallopian Tube Neoplasms - pathology</topic><topic>Fallopian Tube Neoplasms - surgery</topic><topic>Fallopian tubes</topic><topic>Female</topic><topic>Gynecology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immunohistochemistry - standards</topic><topic>Laboratory Medicine</topic><topic>Libraries</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Molecular Diagnostic Techniques - standards</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>original-article</topic><topic>Ovarian Neoplasms - chemistry</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Ovaries</topic><topic>Pathology</topic><topic>Pathology, Clinical - standards</topic><topic>Peritoneal Neoplasms - chemistry</topic><topic>Peritoneal Neoplasms - drug therapy</topic><topic>Peritoneal Neoplasms - genetics</topic><topic>Peritoneal Neoplasms - pathology</topic><topic>Peritoneal Neoplasms - surgery</topic><topic>Predictive Value of Tests</topic><topic>Research Design - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McCluggage, W Glenn</creatorcontrib><creatorcontrib>Judge, Meagan J</creatorcontrib><creatorcontrib>Clarke, Blaise A</creatorcontrib><creatorcontrib>Davidson, Ben</creatorcontrib><creatorcontrib>Gilks, C Blake</creatorcontrib><creatorcontrib>Hollema, Harry</creatorcontrib><creatorcontrib>Ledermann, Jonathan A</creatorcontrib><creatorcontrib>Matias-Guiu, Xavier</creatorcontrib><creatorcontrib>Mikami, Yoshiki</creatorcontrib><creatorcontrib>Stewart, Colin JR</creatorcontrib><creatorcontrib>Vang, Russell</creatorcontrib><creatorcontrib>Hirschowitz, Lynn</creatorcontrib><creatorcontrib>International Collaboration on Cancer Reporting</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Modern pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McCluggage, W Glenn</au><au>Judge, Meagan J</au><au>Clarke, Blaise A</au><au>Davidson, Ben</au><au>Gilks, C Blake</au><au>Hollema, Harry</au><au>Ledermann, Jonathan A</au><au>Matias-Guiu, Xavier</au><au>Mikami, Yoshiki</au><au>Stewart, Colin JR</au><au>Vang, Russell</au><au>Hirschowitz, Lynn</au><aucorp>International Collaboration on Cancer Reporting</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)</atitle><jtitle>Modern pathology</jtitle><stitle>Mod Pathol</stitle><addtitle>Mod Pathol</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>28</volume><issue>8</issue><spage>1101</spage><epage>1122</epage><pages>1101-1122</pages><issn>0893-3952</issn><eissn>1530-0285</eissn><coden>MODPEO</coden><abstract>A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but these vary in their content. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, with the aim of developing an evidence-based reporting data set for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of primary ovarian, fallopian tube and peritoneal carcinoma and present the ‘required’ and ‘recommended’ elements to be included in the report with an explanatory commentary. This data set encompasses the recent International Federation of Obstetricians and Gynaecologists staging system for these neoplasms and the updated World Health Organisation Classification of Tumours of the Female Reproductive Organs. The data set also addresses issues about site assignment of the primary tumour in high-grade serous carcinomas and proposes a scoring system for the assessment of tumour response to neoadjuvant chemotherapy. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and hopefully will result in improved patient management.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>26089092</pmid><doi>10.1038/modpathol.2015.77</doi><tpages>22</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-3952 |
ispartof | Modern pathology, 2015-08, Vol.28 (8), p.1101-1122 |
issn | 0893-3952 1530-0285 |
language | eng |
recordid | cdi_proquest_miscellaneous_1720454624 |
source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library |
subjects | 13/51 692/420 692/420/755 692/699 692/699/67/1517/1709 Alliances Biomarkers, Tumor - analysis Biomarkers, Tumor - genetics Biopsy - standards Cancer Carcinoma - chemistry Carcinoma - drug therapy Carcinoma - genetics Carcinoma - pathology Carcinoma - surgery Chemotherapy, Adjuvant Collaboration Datasets Diagnosis, Differential Fallopian Tube Neoplasms - chemistry Fallopian Tube Neoplasms - drug therapy Fallopian Tube Neoplasms - genetics Fallopian Tube Neoplasms - pathology Fallopian Tube Neoplasms - surgery Fallopian tubes Female Gynecology Hospitals Humans Immunohistochemistry - standards Laboratory Medicine Libraries Medicine Medicine & Public Health Molecular Diagnostic Techniques - standards Neoadjuvant Therapy Neoplasm Grading Neoplasm Staging original-article Ovarian Neoplasms - chemistry Ovarian Neoplasms - drug therapy Ovarian Neoplasms - genetics Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Ovaries Pathology Pathology, Clinical - standards Peritoneal Neoplasms - chemistry Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - genetics Peritoneal Neoplasms - pathology Peritoneal Neoplasms - surgery Predictive Value of Tests Research Design - standards |
title | Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A44%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Data%20set%20for%20reporting%20of%20ovary,%20fallopian%20tube%20and%20primary%20peritoneal%20carcinoma:%20recommendations%20from%20the%20International%20Collaboration%20on%20Cancer%20Reporting%20(ICCR)&rft.jtitle=Modern%20pathology&rft.au=McCluggage,%20W%20Glenn&rft.aucorp=International%20Collaboration%20on%20Cancer%20Reporting&rft.date=2015-08-01&rft.volume=28&rft.issue=8&rft.spage=1101&rft.epage=1122&rft.pages=1101-1122&rft.issn=0893-3952&rft.eissn=1530-0285&rft.coden=MODPEO&rft_id=info:doi/10.1038/modpathol.2015.77&rft_dat=%3Cproquest_cross%3E1720454624%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1700330693&rft_id=info:pmid/26089092&rfr_iscdi=true |